Doug Fambrough | Chief Executive Officer |
Doug Pagan | Chief Financial Officer |
Shreeram Aradhye | Chief Medical Officer |
Jim Weissman | Chief Operating Officer |
Rob Ciappenelli | Chief Commercial Officer |
Bob Brown | Chief Scientific Officer |
Tierney | Attorney |
Jonathan Miller | Evercore ISI |
Rick | SVB Leerink |
Madhu Kumar | Goldman Sachs |
Stephen Willey | Stifel |
Brandon | Cowen |
Luca Issi | RBC Capital |
Yigal Nochomovitz | Citigroup |
Mayank Mamtani | B. Riley Securities |
Good morning, ladies and gentlemen, and welcome to the Dicerna Pharmaceutical's Second Quarter 2021 Earnings Conference Call.
As a reminder, this conference is being recorded at the Company's request. I will now turn the call over to your host, Attorney Solvix [Indiscernable] .Please go ahead.
Thank you, Operator. Good morning, everyone, and thank you for joining us to review Dicerna 's Second Quarter 2021 financial results and operational highlights.